Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir

Drug Design Development and Therapy ◽

10.2147/dddt.s65349 ◽

2014 ◽

pp. 869 ◽

Cited By ~ 8

Author(s):

Fumitaka Suzuki ◽

Hitomi Sezaki ◽

Norio Akuta ◽

Yoshiyuki Suzuki ◽

Yusuke Kawamura ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Combination Treatment ◽

Tenofovir Disoproxil Fumarate ◽

Virologic Breakthrough

Download Full-text

Virologic analysis of tenofovir resistance in a patient with chronic hepatitis B experiencing viral breakthrough during combination treatment with tenofovir disoproxil fumarate and entecavir

Hepatology Research ◽

10.1111/hepr.13618 ◽

2021 ◽

Author(s):

Fumitaka Suzuki ◽

Hitomi Sezaki ◽

Tetsuya Hosaka ◽

Yoshiyuki Suzuki ◽

Shunichiro Fujiyama ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Combination Treatment ◽

Tenofovir Disoproxil Fumarate ◽

Viral Breakthrough

Download Full-text

Faculty Opinions recommendation of Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969434.793470533 ◽

2013 ◽

Author(s):

Cihan Yurdaydin

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Open Label ◽

Follow Up Study

Download Full-text

Reactivation of chronic hepatitis B during treatment with tenofovir disoproxil fumarate: drug interactions or low adherence?: Table 1

BMJ Case Reports ◽

10.1136/bcr-2015-209586 ◽

2015 ◽

pp. bcr2015209586 ◽

Cited By ~ 5

Author(s):

Benedetto Caroleo ◽

Orietta Staltari ◽

Luca Gallelli ◽

Francesco Perticone

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Drug Interactions ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate

Download Full-text

Changes in bone mineral density during monotherapy with tenofovir disoproxil fumarate: a 6-year real life longitudinal cohort study in chronic hepatitis B caucasian patients

Digestive and Liver Disease ◽

10.1016/j.dld.2019.12.108 ◽

2020 ◽

Vol 52 ◽

pp. e27

Author(s):

M. Viganò ◽

A. Loglio ◽

F. Cerini ◽

E. Farina ◽

F. Facchetti ◽

...

Keyword(s):

Bone Mineral Density ◽

Chronic Hepatitis ◽

Cohort Study ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Bone Mineral ◽

Tenofovir Disoproxil Fumarate ◽

Real Life ◽

Mineral Density ◽

Caucasian Patients

Download Full-text

M1908 Tenofovir Disoproxil Fumarate (TDF) for the Treatment of HBeAg-Negative Chronic Hepatitis B: Week 72 TDF Data and Week 24 Adefovir Dipivoxil Switch Data (Study 102)

Gastroenterology ◽

10.1016/s0016-5085(08)63776-2 ◽

2008 ◽

Vol 134 (4) ◽

pp. A-808 ◽

Cited By ~ 1

Author(s):

Patrick Marcellin ◽

Ira M. Jacobson ◽

Naoky Tsai ◽

Natalie Bzowej ◽

François Habersetzer ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Adefovir Dipivoxil ◽

Negative Chronic Hepatitis

Download Full-text

[519] RAPID VIRAL SUPPRESSION CAN PREDICT SUSTAINED VIROLOGICAL RESPONSE TO PEGINTERFERON AND LAMIVUDINE COMBINATION TREATMENT IN CHRONIC HEPATITIS B

Journal of Hepatology ◽

10.1016/s0168-8278(07)62117-5 ◽

2007 ◽

Vol 46 ◽

pp. S197-S198

Author(s):

J.J.Y. Sung ◽

B.W.S. Wong ◽

A.M.L. Chim ◽

H.Y. Chan ◽

A.Y. Hui ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Sustained Virological Response ◽

Chronic Hepatitis B ◽

Combination Treatment ◽

Virological Response ◽

Viral Suppression

Download Full-text

20 THREE YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBEAG-NEGATIVE AND POSITIVE PATIENTS WITH CHRONIC HEPATITIS B (STUDY 102 AND STUDY 103)

Digestive and Liver Disease ◽

10.1016/s1590-8658(10)60390-8 ◽

2010 ◽

Vol 42 ◽

pp. S8-S9

Author(s):

M. Rizzetto ◽

P. Marcellin ◽

E.J. Heathcote ◽

J. Sorbel ◽

E. Mondou ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate

Download Full-text

Insufficient immunity led to virologic breakthrough in NAs-treated chronic hepatitis B patients switching to Peg–IFN–ɑ

Antiviral Research ◽

10.1016/j.antiviral.2021.105220 ◽

2021 ◽

pp. 105220

Author(s):

Da Huang ◽

Weiming Yan ◽

Meifang Han ◽

Wei Yuan ◽

Peng Wang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Virologic Breakthrough

Download Full-text

Real-world single-center experience with entecavir and tenofovir disoproxil fumarate in treatment-naïve and experienced patients with chronic hepatitis B

Saudi Journal of Gastroenterology ◽

10.4103/sjg.sjg_49_18 ◽

2018 ◽

Vol 24 (6) ◽

pp. 326 ◽

Cited By ~ 11

Author(s):

HyunPhil Shin ◽

YoungMin Kim ◽

JoungIl Lee ◽

KwangRo Joo ◽

JaeMyung Cha ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Real World ◽

Tenofovir Disoproxil Fumarate ◽

Single Center ◽

Single Center Experience ◽

Treatment Naïve

Download Full-text

Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: A European multicenter study

Antiviral Research ◽

10.1016/j.antiviral.2011.07.003 ◽

2011 ◽

Vol 92 (1) ◽

pp. 90-95 ◽

Cited By ~ 21

Author(s):

Si-Nafa Si-Ahmed ◽

Pierre Pradat ◽

Roeland Zoutendijk ◽

Maria Buti ◽

Vincent Mallet ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Multicenter Study ◽

Tenofovir Disoproxil Fumarate ◽

European Multicenter Study

Download Full-text